Waiting
Login processing...

Trial ends in Request Full Access Tell Your Colleague About Jove
JoVE Journal
Immunology and Infection

A subscription to JoVE is required to view this content.
You will only be able to see the first 2 minutes.

Lentiviral CRISPR/Cas9-mediert Genova redigering for studier av blodkreft celler i sykdom modeller
 
Click here for the English version

Lentiviral CRISPR/Cas9-mediert Genova redigering for studier av blodkreft celler i sykdom modeller

Article DOI: 10.3791/59977-v
October 3rd, 2019

Chapters

Summary October 3rd, 2019

Please note that all translations are automatically generated.

Click here for the English version.

Beskrevet er protokoller for svært effektiv Genova redigering av murine blodkreft stem og stamceller (HSPC) av CRISPR/Cas9 system for å raskt utvikle musemodell systemer med blodkreft system-spesifikke gen modifikasjoner.

Transcript

Read Article

Get cutting-edge science videos from JoVE sent straight to your inbox every month.

Waiting X
Simple Hit Counter